K. West

发表

Prevalence of Frailty in Patients Referred to the Kidney Transplant Waitlist

N. Tangri, K. Rockwood, B. Kiberd, 2021, Kidney360.

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.

K. West, I. Sketris, P. Belitsky, 1999, Transplantation.

Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk

B. Kiberd, K. West, K. Tennankore, 2014, Transplantation research.

Frailty Severity and Hospitalization After Dialysis Initiation

Arsh K Jain, K. Rockwood, A. Vinson, 2021, Canadian journal of kidney health and disease.

Targeting cardiovascular risk in renal transplantation.

B. Kiberd, K. West, 2001, Transplantation proceedings.

Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.

B. Kiberd, K. West, Vivian Charles McAlister, 2001, Journal of the American Society of Nephrology : JASN.

The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study

B. Kiberd, A. Vinson, L. Gunaratnam, 2022, Kidney360.

Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling

B. Kiberd, C. Clase, K. West, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients.

B. Kiberd, K. West, K. Kamal, 2003, Transplantation proceedings.

Disparities in Access to Preemptive Repeat Kidney Transplant: Still Missing the Mark?

B. Kiberd, A. Vinson, K. West, 2021, Kidney360.

Alloimmune thrombocytopenia after organ transplantation.

J. Kelton, K. West, Vivian Charles McAlister, 1999, The New England journal of medicine.

Kidney transplantation, the Halifax experience.

B. Kiberd, K. West, I. Sketris, 1996, Clinical transplants.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study

S. Soroka, B. Kiberd, K. West, 2011, BMC nephrology.

Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.

B. Kiberd, K. West, Vivian Charles McAlister, 1997, Transplantation proceedings.

Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study

N. Tangri, S. Doucette, B. Kiberd, 2020, Canadian journal of kidney health and disease.

A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.

B. Kiberd, K. West, Vivian Charles McAlister, 2000, Transplantation proceedings.

Successful Use of Kidneys from a Deceased Donor with Active Herpes Zoster Infection

A. Vinson, K. West, K. Tennankore, 2021, Case reports in transplantation.

CAN “AREA UNDER THE CURVE” BASED ON ABBREVIATED PHARMACOKINETICS BE USED FOR CYCLOSPORINE MICROEMULSION (NEORAL®) MONITORING IN KIDNEY TRANSPLANT RECEPIENTS?

K. West, I. Sketris, P. Belitsky, 1998 .

Medication Reimbursement Model and Cost Savings in a Canadian Ambulatory Hemodialysis Program.

S. Soroka, K. West, Jo-Anne S Wilson, 2019, The Canadian journal of hospital pharmacy.

Feasibility of Twice-Weekly Hemodialysis: Contingency Planning for COVID-19

K. West, K. Tennankore, D. Clark, 2021, Kidney Medicine.

Multiview Clustering to Identify Novel Kidney Donor Phenotypes for Assessing Graft Survival in Older Transplant Recipients

B. Kiberd, George Worthen, A. Vinson, 2023, Kidney360.